Background illustration for clinical trials search

Paid Clinical Trials Tuscaloosa

Discover 859 paid clinical trials in Tuscaloosa, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.

for
Refractory Angina, Coronary Artery Disease
Location: Birmingham AL, Atlanta GA, Cincinnati OH, Durham NC,
Sponsor: XyloCor Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07048808

Phase2, Recruiting

BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease

for
HR+/HER2- Breast Cancer
Location: Birmingham AL, Owensboro KY, Hendersonville NC,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT07492641

Phase3, Recruiting

Psilocybin-facilitated Treatment for Chronic Pain

for
Fibromyalgia, Primary
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: Female

Age: 25 - 65

Code: NCT05068791

Early_phase1, Recruiting

A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis

for
Psoriasis
Location: Birmingham AL, San Antonio TX, Chula Vista CA
Sponsor: InventisBio Co., Ltd

Sex: All

Age: 18 - 70

Code: NCT07489885

Phase2, Recruiting

Paclitaxel-Coated Balloon Treatment of Chronic Rhinosinusitis

for
Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps
Location: Birmingham AL, Louisville KY, Charleston SC, Dallas TX,
Sponsor: Airiver Medical, Inc.

Sex: All

Age: 18+

Code: NCT07290140

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab

for
Relapsing Multiple Sclerosis
Location: Birmingham AL, Cullman AL, Atlanta GA, Knoxville TN,
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18 - 65

Code: NCT05877963

Phase3, Recruiting

A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

for
Atopic Dermatitis
Location: Birmingham AL, Macon GA, North Little Rock AR,
Sponsor: LEO Pharma

Sex: All

Age: 0 - 11

Code: NCT06311682

Phase3, Recruiting

ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults

for
Asthma
Location: Birmingham AL, Albany GA, Owensboro KY, Maryville IL,
Sponsor: Enveda Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07301255

Phase2, Recruiting

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

for
Relapsing Multiple Sclerosis, Multiple Sclerosis
Location: Birmingham AL, Cullman AL, Huntsville AL, Mobile AL,
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06433752

Recruiting
New

A Study to Assess the Efficacy and Safety of GIA632 Across a Range of Doses in Participants With Moderate to Severe Cutaneous Lichen Planus

for
Cutaneous Lichen Planus
Location: Birmingham AL, New Orleans LA, Indianapolis IN,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07775924

Phase2, Recruiting

VALOR: Vaginal Atrophy & Long-term Observation of Recovery

for
Atrophic Vaginitis, Vaginal Atrophy,
Location: Birmingham AL, West Columbia SC, Fayetteville NC,
Sponsor: Stratpharma AG

Sex: Female

Age: 18+

Code: NCT05953090

Recruiting

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

for
Atopic Dermatitis
Location: Birmingham AL, North Little Rock AR, Greenville SC,
Sponsor: Pfizer

Sex: All

Age: 2 - 11

Code: NCT06807281

Phase3, Recruiting

A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)

for
Chronic Inducible Urticaria, Cold Urticaria,
Location: Birmingham AL, Columbus GA, Bowling Green KY,
Sponsor: Celldex Therapeutics

Sex: All

Age: 18+

Code: NCT07266402

Phase3, Recruiting

This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

for
Atopic Dermatitis
Location: Birmingham AL, Montgomery AL, Macon GA, Spartanburg SC,
Sponsor: Sanofi

Sex: All

Age: 12+

Code: NCT07290803

Recruiting

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

for
Atopic Dermatitis, Atopic, Dermatitis, Dermatitis, Atopic,
Location: Birmingham AL, Bryant AR, Clarksville IN,
Sponsor: Apollo Therapeutics Ltd

Sex: All

Age: 18 - 65

Code: NCT07599813

Phase2, Recruiting

Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis

for
Prurigo Nodularis (PN)
Location: Birmingham AL, Indianapolis IN, Mayfield Heights OH,
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.

Sex: All

Age: 18 - 70+

Code: NCT07236099

Phase2, Recruiting

A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines

for
Chronic Spontaneous Urticaria (CSU)
Location: Birmingham AL, Columbus GA, Douglasville GA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06868212

Phase3, Recruiting

A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema

for
Eczema
Location: Birmingham AL, North Little Rock AR, Greenville SC,
Sponsor: Pfizer

Sex: All

Age: 6 - 11

Code: NCT06807268

Phase3, Recruiting

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Location: Birmingham AL, Nashville TN, Baton Rouge LA,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06129864

Phase3, Recruiting

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

for
Relapsed/Refractory Multiple Myeloma
Location: Birmingham AL, Atlanta GA, Nashville TN,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT05850234

Phase1, Phase2, Recruiting